Promising drugs and treatment options for pediatric and adolescent patients with Hodgkin lymphoma

Promising drugs and treatment options for pediatric and adolescent patients with Hodgkin lymphoma

Currently-available therapies for newly-diagnosed pediatric and adolescent patients with Hodgkin lymphoma result in >95% survival at 5 years. Long-term survivors may suffer from long-term treatment-related side effects, however, so the past 20 years have seen clinical trials for children and...

Full description

Bibliographic Details
Main Authors: Valli De Re, Ombretta Repetto, Lara Mussolin, Giulia Brisotto, Caterina Elia, Egesta Lopci, Emanuele S. G. d’Amore, Roberta Burnelli, Maurizio Mascarin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-11-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
Hodgkin lymphoma
Epstein-Barr virus
chemotherapy
radiation
tumor target
adolescent
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2022.965803/full

Internet

https://www.frontiersin.org/articles/10.3389/fcell.2022.965803/full

Similar Items